quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:08:21·836d
SECFiling
PepperLime Health Acquisition Corporation Warrrant logo

PepperLime Health Acquisition Corporation Warrrant filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

PEPLW· PepperLime Health Acquisition Corporation Warrrant
Finance
Original source

Companies

  • PEPLW
    PepperLime Health Acquisition Corporation Warrrant
    Finance

Related

  • SEC759d
    SEC Form 15-12G filed by PepperLime Health Acquisition Corporation Warrrant
  • SEC763d
    SEC Form 25-NSE filed by PepperLime Health Acquisition Corporation Warrrant
  • SEC770d
    PepperLime Health Acquisition Corporation Warrrant filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC773d
    PepperLime Health Acquisition Corporation Warrrant filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
  • SEC787d
    PepperLime Health Acquisition Corporation Warrrant filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
  • 13D/G791d
    SEC Form SC 13G/A filed by PepperLime Health Acquisition Corporation Warrrant (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by PepperLime Health Acquisition Corporation Warrrant (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by PepperLime Health Acquisition Corporation Warrrant (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022